Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?

被引：14

作者：

Loh, Huai Heng ^{[1
]}

Sukor, Norlela ^{[2
]}

机构：

[1] Univ Malaysia Sarawak, Fac Med & Hlth Sci, Sarawak, Malaysia

[2] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Med, Kuala Lumpur, Malaysia

来源：

JOURNAL OF HUMAN HYPERTENSION | 2020年 / 34卷 / 01期

关键词：

RENIN-ANGIOTENSIN-ALDOSTERONE; SUBCLINICAL CUSHINGS-SYNDROME; TREATED PRIMARY ALDOSTERONISM; CONGESTIVE-HEART-FAILURE; PRIMARY HYPERPARATHYROIDISM; RESISTANT HYPERTENSION; INSULIN SENSITIVITY; PARATHYROID-HORMONE; OXIDATIVE STRESS; BLOOD-PRESSURE;

D O I：

10.1038/s41371-019-0294-8

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Primary aldosteronism (PA), the most common cause of secondary hypertension, is a well-recognized condition that can lead to cardiovascular and renal complications. PA is frequently left undiagnosed and untreated, leading to aldosterone-specific morbidity and mortality. In this review we highlight the evidence linking PA with other conditions such as (i) diabetes mellitus, (ii) obstructive sleep apnea, and (iii) bone health, along with clinical implications and proposed underlying mechanisms.

引用

页码：5 / 15

页数：11

共 112 条

[11] Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea
Calhoun, DA
Nishizaka, MK
Zaman, MA
Harding, SM
[J]. CHEST, 2004, 125 (01) : 112 - 117
[12] In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess
Campión, J
Lahera, V
Cachofeiro, V
Maestro, B
Dávila, N
Carranza, MD
Calle, C
[J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 185 (1-2) : 177 - 182
[13] Fracture risk in men with congestive heart failure - Risk reduction with spironolactone
Carbone, Laura D.
Cross, Jessica D.
Raza, Syed H.
Bush, Andrew J.
Sepanski, Robert J.
Dhawan, Saurabh
Khan, Bilal Q.
Gupta, Malini
Ahmad, Khurram
Khouzam, Rami N.
Dishmon, Dwight A.
Nesheiwat, Joseph P.
Hajjar, Mohammad A.
Chishti, Waqas A.
Nasser, Wael
Khan, Mehwish
Womack, Catherine R.
Cho, Tara
Haskin, Ashley R.
Weber, Karl T.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (02) : 135 - 138
[14] Aldosterone Enhances IGF-I-Mediated Signaling and Biological Function in Vascular Smooth Muscle Cells
Cascella, Teresa
Radhakrishnan, Yashwanth
Maile, Laura A.
Busby, Walker H., Jr.
Gollahon, Katherine
Colao, Annamaria
Clemmons, David R.
[J]. ENDOCRINOLOGY, 2010, 151 (12) : 5851 - 5864
[15] Cardiovascular outcomes in patients with primary aldosteronism after treatment
Catena, Cristiana
Colussi, GianLuca
Nadalini, Elisa
Chiuch, Alessandra
Baroselli, Sara
Lapenna, Roberta
Sechi, Leonardo A.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) : 80 - 85
[16] Insulin sensitivity in patients with primary aldosteronism: A follow-up study
Catena, Cristiana
Lapenna, Roberta
Baroselli, Sara
Nadalini, Elisa
Colussi, GianLuca
Novello, Marileda
Favret, Grazia
Melis, Alessandra
Cavarape, Alessandro
Sechi, Leonardo A.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) : 3457 - 3463
[17] Bone health and aldosterone excess
Ceccoli, L.
Ronconi, V.
Giovannini, L.
Marcheggiani, M.
Turchi, F.
Boscaro, M.
Giacchetti, G.
[J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (11) : 2801 - 2807
[18] Chanut Francoise, 2006, PLoS Biol, V4, pe53, DOI 10.1371/journal.pbio.0040053
[19] Primary Aldosteronism and Cerebrovascular Diseases
Chen, Zheng-Wei
Hung, Chi-Sheng
Wu, Vin-Cent
Lin, Yen-Hung
[J]. ENDOCRINOLOGY AND METABOLISM, 2018, 33 (04) : 429 - 434
[20] NORMOKALEMIC PRIMARY ALDOSTERONISM - A DETECTABLE CAUSE OF CURABLE ESSENTIAL HYPERTENSION
CONN, JW
COHEN, EL
ROVNER, DR
NESBIT, RM
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (03): : 200 - &

← 1 2 3 4 5 6 7 8 9 10 →